Sai Life Sciences Limited has announced that it will host an earnings conference call on Friday, 6th February 2026, at 04:00 PM (IST). The purpose of the call is to discuss the unaudited financial results of the company for the third quarter and nine months ended 31 December 2025. The company has provided dial-in numbers for participants, including international toll-free numbers for the USA, UK, Singapore, and Hong Kong. A pre-registration facility is available for participants to dial in directly without waiting for the operator. The conference call will begin with a brief management discussion on the earnings performance, followed by an interactive Question & Answer session. The management representation will include Mr. Krishna Kanumuri, Managing Director & Chief Executive Officer, and Mr. Siva Chittor, Director and Chief Financial Officer. Sai Life Sciences is a global Contract Research, Development, and Manufacturing Organization (CRDMO) that partners with innovator pharmaceutical and biotech companies. Headquartered in Hyderabad, India, the company offers integrated solutions and is committed to delivering high-quality, cost-effective, and scalable solutions.
